crc press - E-Lib FK UWKS

More documents

Recommendations

Info

Editor Ülo Langel is a professor at the department of neurochemistry and neurotoxicology, Stockholm University, Sweden. Dr. Langel graduated from Tartu University, Tartu, Estonia, as a bioorganic chemist in 1974; he has received his Ph.D. twice: in 1980 from Tartu University (bioorganic chemistry), and in 1993 from Tartu University and Stockholm University (biochemistry and neurochemistry). His professional experience includes a career at Tartu University (from junior research fellow to associate professor and visiting professor, from 1974 to the present); The Scripps Research Institute, La Jolla, California (associate professor, 2000 to 2001); and Stockholm University (from research fellow to associate professor and professor, from 1987 to the present). Professor Langel has been selected as a fellow member of the International Neuropeptide Society (1995), and is also a member of the International Society for Neurochemistry, European Peptide Society, Swedish Biochemical Society, and Estonian Biochemical Society. He has been awarded a White Star Order, 4th class, by Estonian Republic. Dr. Langel has been an invited lecturer at numerous international conferences and is co-author of more than 140 scientific articles and 5 patents.
Page 2 and 3: CELL- PENETRATING PEPTIDES Processe
Page 4 and 5: Pharmacology and Toxicology: Basic
Page 7 and 8: Library of Congress Cataloging-in-P
Page 9 and 10: to the handbook are prominent resea
Page 11: REFERENCES 1. Green, M. and Loewens
Page 15 and 16: Liam Good Center for Genomics and B
Page 17 and 18: Lee Wright CellGate Inc. Sunnyvale,
Page 19 and 20: Section II Mechanisms of Cell Penet
Page 22: Section I Classes of Cell-Penetrati
Page 25 and 26: 4 Cell-Penetrating Peptides: Proces
Page 31 and 32: 10 Cell-Penetrating Peptides: Proce
Page 44 and 45: 2 Penetratins CONTENTS 0-8493-1141-
Page 46 and 47: Penetratins 25 TABLE 2.1 Behavior o
Page 48 and 49: Penetratins 27 there a chiral recog
Page 50 and 51: Penetratins 29 In a second set of e
Page 52 and 53: Penetratins 31 2.4 DELIVERY OF HYDR
Page 54 and 55: Penetratins 33 TABLE 2.3 (continued
Page 56 and 57: Penetratins 35 In a more recent rep
Page 58 and 59: Penetratins 37 2.4.3.1.2 Regulation
Page 60 and 61: Penetratins 39 2.4.4 IN VIVO INTERN
Page 62 and 63:
Penetratins 41 2. Add 10 to 50 mola
Page 64 and 65:
Penetratins 43 see Reference 31). C
Page 66 and 67:
Penetratins 45 FCS (10%) or horse s
Page 68 and 69:
Penetratins 47 2.5.3.2 Oligonucleot
Page 70 and 71:
Penetratins 49 28. Derossi, D. et a
Page 72:
Penetratins 51 70. Chatelin, L. et
Page 75 and 76:
54 Cell-Penetrating Peptides: Proce
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
100 Cell-Penetrating Peptides: Proc
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 136 and 137:
6 CONTENTS 0-8493-1141-1/02/$0.00+$
Page 138 and 139:
Hydrophobic Membrane Translocating
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
Page 156 and 157:
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
7 CONTENTS 0-8493-1141-1/02/$0.00+$
Page 164 and 165:
Arginine-Rich Molecular Transporter
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Page 174 and 175:
Page 176 and 177:
Page 178 and 179:
Page 180 and 181:
Page 182:
Section II Mechanisms of Cell Penet
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
A FIGURE 9.4 Pex file example (top)
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 284 and 285:
12 CONTENTS 0-8493-1141-1/02/$0.00+
Page 286 and 287:
Quantification of Cell-Penetrating
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Page 294 and 295:
Page 296:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 316 and 317:
14 CONTENTS 0-8493-1141-1/02/$0.00+
Page 318 and 319:
Signal Peptides 297 1. In the cytos
Page 320 and 321:
Signal Peptides 299 that binds dena
Page 322 and 323:
Signal Peptides 301 more important
Page 324 and 325:
Signal Peptides 303 peptides are th
Page 326 and 327:
Signal Peptides 305 chaperone. 142,
Page 328 and 329:
Signal Peptides 307 14.4.2.2 Specif
Page 330 and 331:
Signal Peptides 309 The specificity
Page 332 and 333:
Signal Peptides 311 14.5.1.1 Weight
Page 334 and 335:
Signal Peptides 313 Recently, an ob
Page 336 and 337:
Signal Peptides 315 23. Park, S. et
Page 338 and 339:
Signal Peptides 317 66. Cleverley,
Page 340 and 341:
Signal Peptides 319 108. Schueneman
Page 342 and 343:
Signal Peptides 321 151. Martoglio,
Page 344 and 345:
Signal Peptides 323 192. Beck, K. e
Page 346:
Section III Applications of Cell-Pe
Page 349 and 350:
Page 351 and 352:
Page 353 and 354:
Page 355 and 356:
Page 357 and 358:
Page 359 and 360:
Page 361 and 362:
Page 363 and 364:
Page 365 and 366:
Page 367 and 368:
Page 369 and 370:
Page 371 and 372:
Page 373 and 374:
TABLE 16.1 Examples of Transport of
Page 375 and 376:
Page 377 and 378:
Page 379 and 380:
Page 381 and 382:
Page 383 and 384:
Page 386 and 387:
17 CONTENTS 0-8493-1141-1/02/$0.00+
Page 388 and 389:
Protein Transport 367 cellular upta
Page 390 and 391:
Protein Transport 369 refolded corr
Page 392 and 393:
Protein Transport 371 LacZ LoxP : %
Page 394 and 395:
Protein Transport 373 for endogenou
Page 396:
Protein Transport 375 29. Embury, J
Page 399 and 400:
Page 401 and 402:
Page 403 and 404:
Page 405 and 406:
Page 407 and 408:
Page 409 and 410:
Page 411 and 412:
TABLE 18.2 Antimicrobial Peptides o
Page 413 and 414:
Page 415 and 416:
Page 417 and 418:
Page 419 and 420:
Page 421 and 422:
Page 423 and 424:
Page 425 and 426:
Page 427:
show all

crc press - E-Lib FK UWKS

Create successful ePaper yourself

Delete template?

Save as template?